Forconti Medical

Company Overview

Snapshot

Founded in February 2011 by Haim Ackerman, Forconti Medical operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its flagship product, Contix, a disposable device for fecal incontinence management. Forconti Medical has successfully completed a pilot clinical trial for Contix at Shaarey Zedek Medical Center in Israel.

Business overview

Forconti Medical develops and produces disposable medical devices designed for the treatment of fecal incontinence. Its core product, Contix, is a non-invasive, AI-powered wearable continence management system that offers an alternative to existing solutions like adult diapers. The device is engineered for placement higher in the anal canal, a less sensitive area of the rectum, aiming to improve patient outcomes and reduce healthcare costs. The company serves the healthcare and medical devices industries, targeting providers, patients, and distributors globally within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Forconti Medical's primary product?

Forconti Medical's primary product is Contix, a disposable medical device designed for the treatment of fecal incontinence. It is a non-invasive, AI-powered wearable continence management system.

When was Forconti Medical founded?

Forconti Medical was founded in February 2011.

Who founded Forconti Medical?

Forconti Medical was founded by Haim Ackerman, who also serves as Chairman & CEO.

What is the current development stage of Forconti Medical's product?

Forconti Medical's product, Contix, is currently in the Clinical Trial stage. The company has completed a pilot clinical trial at Shaarey Zedek Medical Center and is continuing studies at Sheba Medical Center at Tel Hashomer.

Does Forconti Medical hold any patents for its technology?

Yes, Forconti Medical's products are protected by a U.S. and Israeli patent issued in 2016, with patents pending in Europe.